| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 148.47B | 177.74B | 144.07B | 144.18B | 124.96B | 110.78B |
| Gross Profit | 36.92B | 42.99B | 35.14B | 33.03B | 27.41B | 24.56B |
| EBITDA | 18.45B | 22.13B | 20.25B | 26.64B | 13.78B | 12.19B |
| Net Income | 8.62B | 26.07B | 9.78B | 15.28B | 8.31B | 5.31B |
Balance Sheet | ||||||
| Total Assets | 213.78B | 231.82B | 195.21B | 155.14B | 143.90B | 119.71B |
| Cash, Cash Equivalents and Short-Term Investments | 26.15B | 26.60B | 26.74B | 21.38B | 18.32B | 16.89B |
| Total Debt | 75.23B | 44.20B | 61.92B | 28.08B | 34.30B | 22.85B |
| Total Liabilities | 120.68B | 115.89B | 101.38B | 68.17B | 72.47B | 56.47B |
| Stockholders Equity | 87.76B | 106.94B | 89.00B | 83.42B | 68.11B | 60.17B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.19B | 7.26B | 6.05B | 3.65B | 5.96B |
| Operating Cash Flow | 0.00 | 13.86B | 13.10B | 11.75B | 10.28B | 9.49B |
| Investing Cash Flow | 0.00 | 10.79B | -29.83B | 2.58B | -15.95B | -5.17B |
| Financing Cash Flow | 0.00 | -26.05B | 22.00B | -11.49B | 6.84B | -3.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥16.07B | 7.85 | ― | 2.81% | 0.33% | -1.09% | |
74 Outperform | ¥90.04B | -5.93 | ― | 4.28% | 23.37% | 166.37% | |
72 Outperform | ¥264.23B | 13.42 | 8.53% | 2.45% | 3.59% | 44.73% | |
70 Outperform | ¥120.37B | 8.88 | ― | 1.92% | 13.77% | 39.53% | |
69 Neutral | ¥579.06B | 15.02 | ― | 2.13% | 11.07% | 37.42% | |
67 Neutral | ¥24.17B | 6.90 | ― | 7.56% | 3.74% | -10.06% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |